Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center unites innovative research and compassionate care to prevent and eliminate cancer and infectious disease. We’re driven by the urgency of our patients, the hope of our community, and our passion for discovery to pursue scientific breakthroughs and healthier lives for every person in every community.

In addition to bringing Seattle Cancer Care Alliance and Fred Hutch together as a single organization, we’ve strengthened our relationship with UW Medicine. While Fred Hutch is an independent, nonprofit organization, it will now also serve as the cancer program for UW Medicine. This unique relationship allows for enhanced care coordination with one of the world's leading integrated health systems.

Subscribe to Fred Hutch’s Oncology Insights e-newsletter to gain clinical and research insights from renowned experts.

https://www.fredhutch.org/en.html


 

Myeloma

AML - Keynote - Latest updates on Standard Therapies and Investigational Therapies, MRD in AML, HTC and Non-HCT

Playlist Items:
ASH 2018 AML: Deciding Between Standard vs Investigational Therapies & Problems in Evaluating New Therapies, MRD and HCT, The University of Kansas Cancer Center
ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Related to HCT?, The University of Kansas Cancer Center
ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies, The University of Kansas Cancer Center
ASH 2018 AML Challenges in Evaluating New Therapies: Understanding the Recent FDA Approvals, The University of Kansas Cancer Center
  • 459 views
  • March 19, 2019